LOGIN  |  REGISTER
Cue Biopharma
Astria Therapeutics

Azenta to Participate in Upcoming Investor Conferences

February 28, 2023 | Last Trade: US$51.73 0.19 -0.37

BURLINGTON, Mass., Feb. 28, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in two upcoming investor conferences:

  • Cowen 43rd Annual Health Care Conference in Boston, MA, on Tuesday, March 7th, 2023. Includes a presentation beginning at 12:50 pm ET
  • Barclays Global Healthcare Conference in Miami, FL, on Wednesday, March 15th, 2023. Includes a presentation beginning at 3:35 pm ET

The live webcast of the presentations can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the events.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.

Sherry Dinsmore
This email address is being protected from spambots. You need JavaScript enabled to view it.

Azenta logo (PRNewsfoto/Azenta)

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page